Healx doses first subject in Phase II neurofibromatosis type 1 therapy trial 25 Feb Written By Charlotte Kirby Charlotte Kirby
Healx doses first subject in Phase II neurofibromatosis type 1 therapy trial 25 Feb Written By Charlotte Kirby Charlotte Kirby
